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Oxidative stress mediates apoptosis induced by oxidized low- OXIDIZED LOW-DENSITY LIPOPROTEIN AND
density lipoprotein and oxidized lipoprotein(a). We measured OXIDIZED LIPOPROTEIN(A) STIMULATE
oxidative stress caused by lipoproteins in human umbilical vein O22 FORMATIONendothelial cells and rabbit aorta. Oxidized lipoprotein(a) was
To measure oxidative stress caused by lipoproteins,the more potent stimulus over oxidized low density lipoprotein,
and we believe that both influence the pathogenesis of athero- we used a chemiluminescence assay with lucigenin as a
sclerosis. specific detector for O22. Native (n) lipoproteins had no
(nLDL) or little [nLp(a)] effect on O22 production of
either human endothelial cells (HUVECs) or rabbit
Atherogenic lipoproteins such as low-density lipopro- aorta. However, treatment with oxLDL or oxLp(a) sig-
tein (LDL) and lipoprotein(a) [Lp(a)], particularly in nificantly increased the O22 concentration in both sys-
tems, with oxLp(a) being the more potent stimulus fortheir oxidized form, play a key role in the early phase
O22 generation.of atherogenesis by causing injury to the vascular wall
[1, 2]. The precise mechanisms are still a matter of de-
bate, and the reason for the higher proatherogenic poten- OXIDIZED LOW-DENSITY LIPOPROTEIN AND
tial of Lp(a) in comparison to LDL is unknown [2]. OXIDIZED LIPOPROTEIN(A)
The increased formation of O22 could contribute to INDUCE APOPTOSIS
the inflammatory cascade in the vessel wall [3], leading Apoptosis in HUVECs was detected by an Annexin
to lesion formation, and might cause arterial endothelial assay and by DNA fragmentation and was distinguished
dysfunction, a well-known phenomenon in hypercholes- from necrosis by propidium iodide staining. The incuba-
terolemia and atherosclerosis [4–6]. Indeed, arteries of tion of HUVECs with oxLDL (30 to 200 mg/ml) or ox-
hypercholesterolemic rabbits produce relatively high Lp(a) (30 to 200 mg/ml) resulted in a dose-dependent
amounts of O22 [7]. Another potential mechanism of induction of apoptosis, whereas nLDL had no and
injury might be apoptosis, because vascular regions that nLp(a) had little influence on cell survival.
are prone to develop atherosclerotic lesions are charac- In rabbit aorta, perfusion with oxLDL (300 mg/ml) or
terized by increased cell turnover during the early phase oxLp(a) (30 mg/ml) resulted in a significant induction
of the disease [8]. Apoptosis has also been found in of apoptosis, too, as detected by TUNEL staining of
fragmented DNA (Fig. 1). The induction of apoptosishuman and animal atherosclerotic lesions [9, 10]. Know-
was time dependent and could be detected in endothelialing that the generation of oxygen radicals is involved in
cells and in all layers of smooth muscle cells. nLDL andmediating apoptosis in numerous cells [11, 12], including
nLp(a) had no significant effect. In both HUVECs andendothelial cells [13], and having data suggesting that
aorta, oxLp(a) had the strongest impact on the survivalthe stimuli for vascular O22 formation are oxidized LDL
of the cells. It is tempting to speculate that the higher(oxLDL) and/or oxidized Lp(a) [oxLp(a)] [14], athero-
potency of Lp(a) to induce apoptosis might contributegenic lipoproteins, we hypothesize that oxidized lipopro-
to its higher proatherogenic potential.teins cause vascular apoptosis via stimulation of O22
formation.
APOPTOSIS IS MEDIATED BY
REACTIVE OXYGENKey words: lipoproteins, cell death, atherogenesis, vascular wall injury,
atherosclerosis. To investigate whether or not oxidative stress might
be involved in the induction of apoptosis in HUVECs, we 1999 by the International Society of Nephrology
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Fig. 1. Apoptosis in isolated intact segments of rabbit aorta, intraluminally perfused with oxidized low density lipoprotein (oxLDL, 300 mg/ml;
A) and oxidized lipoprotein(a) [oxLp(a), 30 mg/ml; B] for 6, 12, or 24 hours, the enhancement of apoptosis by the SOD inhibitor diethyl-dithio-
carbamate (DDC, 10 mm), and the inhibition of apoptosis by the O22-metabolizing enzymes SOD (0.1 mm) and catalase (100 U/ml). Apoptosis
was determined by TUNEL staining, and the rate of apoptosis is expressed as a percentage of TUNEL-positive cells. Data are means 6 se of
four experiments. Symbols in A are: (h) control; ( ) oxLDL; ( ) oxidized LDL 1 DDC; ( ) oxidized LDL 1 DDC 1 SOD/cat. Symbols in
B are: (h) control; ( ) oxLp(a); ( ) oxidized Lp(a) 1 DDC; ( ) oxidized Lp(a) 1 DDC 1 SOD/cat. *P , 0.05 oxLDL vs. oxLDL 1 DDC,
respectively. oxLp(a) vs. oxLp(a) 1 DDC; #P , 0.05 oxLDL 1 DDC vs. oxLDL 1 DDC 1 SOD/catalase, respectively. oxLp(a) 1 DDC vs.
oxLp(a) 1 DDC 1 SOD/catalase.
incubated the cells with antioxidants, N-acetylcysteine of caspase 3 were abolished by coincubation with antioxi-
dants NAC or vitamins C and E, again indicating a role(NAC 200 mm), as well as a combination of vitamins C
of oxidative stress. The inhibition of caspase 3-like activ-and E (10 mm each) to prevent oxLDL-induced apopto-
ity with the specific inhibitor Ac-DEVD-CHO (100 mm)sis. In the presence of the O22-catabolizing enzymes super-
completely prevented oxLDL-stimulated apoptosis.oxide dismutase (SOD; 0.1 mm) or catalase (100 U/ml),
the induction of apoptosis induced by oxLDL or by
oxLp(a) was inhibited. When given in combination, SOD LYSOPHOSPHATIDYLCHOLINE IS ENRICHED
and catalase decreased the apoptosis rate below control IN OXIDIZED LOW-DENSITY LIPOPROTEIN
levels. The corresponding experiment in rabbit aorta AND OXIDIZED LIPOPROTEIN(A)
gave similar results: SOD and catalase significantly re-
During the lipoprotein oxidation, various more or less
duced apoptosis (Fig. 1). In agreement with the results stable products are formed by phospholipase A2, includ-obtained in HUVECs, oxLp(a) had the strongest effect. ing lysophosphatidylcholine (lyso-PC), aldehydic lipid
When, on the other hand, HUVECs or aortic segments peroxidation products, and fatty acids [16, 17], some of
were stimulated in the presence of diethyl-dithio-carba- which may stimulate cellular O22-generating enzymes.mate (DDC 10 mm), an inhibitor of endogenous SOD, As a first step in identifying the active component, we
the induction of apoptosis was more than doubled (Fig. compared the concentration of lyso-PC in the different
1). Thus, the stimulation of apoptosis by oxLDL and lipoprotein preparations because lyso-PC has been shown
oxLp(a) seems to be mediated by oxidative stress. to induce O22 formation in rabbit aorta and may be
responsible for some of the pathophysiological effects
of oxLDL and oxLp(a) [18, 19]. As expected, nLDL andCASPASE 3 IS AN EFFECTOR OF OXIDIZED
nLp(a) contained only low amounts of lyso-PC. How-LOW-DENSITY LIPOPROTEIN-INDUCED,
ever, the lyso-PC concentration was increased fivefold inO22-MEDIATED APOPTOSIS
oxLDL compared with nLDL and sevenfold in oxLp(a)
Caspase 3 is a key effector molecule in the cascade compared with nLp(a).
leading to apoptosis [15]. Treatment with oxLDL sig-
nificantly increased caspase 3-like activity in HUVECs.
CONCLUSIONSThis increase was due to cleavage of the procaspase into
the active subunits, as demonstrated by the appearance Oxidized LDL and oxLp(a) induce apoptosis in endo-
thelial cells and aortic segments via oxidative stress, withof the active subunit p17. The activation and cleavage
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